Literature DB >> 2842046

myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines.

B E Johnson1, R W Makuch, A D Simmons, A F Gazdar, D Burch, A W Cashell.   

Abstract

Tumor specimens procured from 38 different small cell lung cancer patients were studied for DNA amplification of the myc family of protooncogenes (c-myc, N-myc, and L-myc). Six of the 38 specimens (16%) had 4-fold or greater myc family DNA amplification (N-myc in 4 and L-myc in 2). All 6 tumors with amplification came from patients who had received combination chemotherapy. The myc family gene copy number of the DNA prepared from 9 tumor cell lines established from these 38 patients was similar to the myc family gene copy number in the DNA prepared from fresh tumor specimens from these same patients. myc family DNA amplification is present in 16% of small cell lung cancer patients' tumors and the amplification pattern in the tumor cell lines is representative of the fresh tumors obtained from the same patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2842046

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Intrachromosomal rearrangements fusing L-myc and rlf in small-cell lung cancer.

Authors:  T P Mäkelä; J Kere; R Winqvist; K Alitalo
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

2.  Cooperation of c-raf-1 and c-myc protooncogenes in the neoplastic transformation of simian virus 40 large tumor antigen-immortalized human bronchial epithelial cells.

Authors:  A M Pfeifer; G E Mark; L Malan-Shibley; S Graziano; P Amstad; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

Review 3.  Lung cancer cell lines as tools for biomedical discovery and research.

Authors:  Adi F Gazdar; Luc Girard; William W Lockwood; Wan L Lam; John D Minna
Journal:  J Natl Cancer Inst       Date:  2010-08-02       Impact factor: 13.506

Review 4.  Unravelling the biology of SCLC: implications for therapy.

Authors:  Joshua K Sabari; Benjamin H Lok; James H Laird; John T Poirier; Charles M Rudin
Journal:  Nat Rev Clin Oncol       Date:  2017-05-23       Impact factor: 66.675

Review 5.  From Mice to Men and Back: An Assessment of Preclinical Model Systems for the Study of Lung Cancers.

Authors:  Adi F Gazdar; Fred R Hirsch; John D Minna
Journal:  J Thorac Oncol       Date:  2015-12-24       Impact factor: 15.609

6.  v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell line.

Authors:  J P Falco; S B Baylin; R Lupu; M Borges; B D Nelkin; R K Jasti; N E Davidson; M Mabry
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Hel-N1: an autoimmune RNA-binding protein with specificity for 3' uridylate-rich untranslated regions of growth factor mRNAs.

Authors:  T D Levine; F Gao; P H King; L G Andrews; J D Keene
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 8.  Cellular and molecular biology of small cell lung cancer: an overview.

Authors:  Niki Karachaliou; Sara Pilotto; Chiara Lazzari; Emilio Bria; Filippo de Marinis; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

9.  Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies.

Authors:  G D Lewis; I Figari; B Fendly; W L Wong; P Carter; C Gorman; H M Shepard
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

10.  Investigation of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: by the FISH technique.

Authors:  T Yakut; U Egeli; C Gebitekin
Journal:  Lung       Date:  2003       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.